# Lilly (Eli) > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v3 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Canonical entity | alpha:company:ed5c886b-f007-4eec-951c-0141de4aae25 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/eli-lilly-co | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 35 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-05T21:30:34.215281+00:00 | | Last reviewed | 2026-09-05T21:30:34.215281+00:00 | ## Identity - Legal name: ELI LILLY & Co - Display name: Lilly (Eli) ## Leadership - David Ricks: Chair. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:3. - Carolyn R. Bertozzi, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:4. - Gabrielle Sulzberger: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5. - J. Erik Fyrwald: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5. - Jamere Jackson: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5. - Jon Moeller: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:4. - Juan R. Luciano: Lead Independent Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5. - Katherine Baicker, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5. - Kimberly Johnson: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5. - Mary Lynne Hedley, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5. - Ralph Alvarez: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5. - William G. Kaelin Jr., M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5. - William Kaelin, Jr.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:6. - Adrienne Brown: Executive Vice President and President, Lilly Immunology. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Anat Hakim: Executive Vice President, General Counsel and Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Carole Ho: Executive Vice President and President, Lilly Neuroscience. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Daniel Skovronsky: Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Laboratories. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - David Ricks: Chair, President, and Chief Executive Officer (CEO). Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Diogo Rau: Executive Vice President and Chief Information and Digital Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Edgardo Hernandez: Executive Vice President and President, Manufacturing Operations. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Eric Dozier: Executive Vice President, Chief People Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Ilya Yuffa: Executive Vice President and President, Lilly USA and Global Customer Capabilities. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Jacob Van Naarden: Executive Vice President, President, Lilly Oncology and Head of Corporate Business Development. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Kenneth Custer: Executive Vice President and President, Lilly Cardiometabolic Health. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Lucas Montarce: Executive Vice President and Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Melissa Seymour: Executive Vice President, Global Quality. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. - Patrik Jonsson: Executive Vice President and President, Lilly International. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ELI LILLY & Co. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1. ## Headquarters - US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Entity Status - Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1. ## Official Website - https://www.lilly.com. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:2. ## Published Fact - US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1. - IN. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1. - Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1. - Drug Manufacturers. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1. - https://www.lilly.com. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:2. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/eli-lilly-co). - alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:2: [ELI LILLY & Co Form 10-K (filed 2026-02-12)](https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/lly-20251231.htm). - alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:3: [Eli Lilly director board source](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:4: [ELI LILLY & Co DEF 14A 2026-03-20](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:5: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:6: [Eli Lilly director board source](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm). - alpha:evidence:company:ed5c886b-f007-4eec-951c-0141de4aae25:7: LLY executive roster source. ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. - Current index memberships: Unavailable - Index membership events: Unavailable ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/eli-lilly-co) - [Public Markdown](https://registry.alpha.ac/companies/eli-lilly-co.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/eli-lilly-co) - [JSON-LD](https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=jsonld) - MCP resource: `alpha://companies/eli-lilly-co` at https://mcp.alpha.ac/mcp